Game Creek Capital’s Amgen AMGN Stock Holding History

Game Creek Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,100	Closed	-$365K	–	83
2017 Q4	$365K	Buy	+2,100	New	+$372K	0.1%	154

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Game Creek Capital's AMGN Position: Q1 2018 in Review

Game Creek Capital sold out of Amgen (AMGN) in Q1 2018, closing a stake of 2,100 shares — an estimated $365K sold.

Game Creek Capital first reported a position in AMGN in Q4 2017 and held it in 1 quarter. The position peaked at $365K in Q4 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

Game Creek Capital reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
Game Creek Capital sold 2,100 Amgen shares in Q1 2018, an estimated $365K.
Game Creek Capital first reported a position in Amgen in Q4 2017 and held it in 1 quarter.
Game Creek Capital's Amgen position peaked at $365K in Q4 2017.
1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Game Creek Capital's 13F filing for Q1 2018, filed 15 May 2018.